Literature DB >> 3930400

Modulation of leukotaxis by ibuprofen. A quantitative determination in vivo.

T Shimanuki, R M Nakamura, G S Dizerega.   

Abstract

The purpose of this study was to evaluate the rabbit anterior eye chamber as a quantitative measure of leukotaxis using 51Cr-labeled homologous leukocytes and then to determine the effects of ibuprofen on N-formyl-methionyl-leucyl-phenylalanine (FMLP) -induced leukotaxis. Leukocyte accumulation was assessed at various intervals (0-24 h) after instillation of FMLP (10(-4) M, 40 microliters) and at various doses (FMLP 10(-6)-10(-4) M). New Zealand white rabbits (2.6-3.0 kg) were treated with ibuprofen for three days with the following regimens: 8.0, 17.5, 35.0, 70.0 mg/kg/ day. Leukocyte quantitation was determined using a direct cell count and recovery of 51Cr-labeled leukocytes from anterior eye chamber aspirations 3 h after their injection into the systemic circulation. FMLP induced a dose-dependent accumulation of leukocytes. Leukocyte influx into the anterior eye chamber increased between 2 and 4 h after FMLP instillation, peaking between 4 and 6 h, then resolving after 8 h. Ibuprofen inhibited leukocyte accumulation into the anterior eye chamber in a dose dependent fashion with a maximum (90.0 +/- 1.4%, X +/- SEM) inhibition with 70 mg/kg/day and an ID50 of 8 mg/kg/day. In conclusion, the anterior eye chamber FMLP-stimulated leukotaxis assay is useful to evaluate the role of pharmacologic agents. Here, ibuprofen was found to inhibit leukotaxis in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930400     DOI: 10.1007/bf00916277

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  Aqueous flare and protein content in the anterior chamber of normal rabbits' eyes.

Authors:  C I ANJOU; C E KRAKAU
Journal:  Acta Ophthalmol (Copenh)       Date:  1961

2.  Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro.

Authors:  K A Brown; A J Collins
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

3.  Acute inflammatory pulmonary reactions induced by chemotactic factors.

Authors:  U Desai; D L Kreutzer; H Showell; C V Arroyave; P A Ward
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

4.  Neutrophil accumulation in vivo following the administration of chemotactic factors.

Authors:  D G Jones; D L Richardson; A B Kay
Journal:  Br J Haematol       Date:  1977-01       Impact factor: 6.998

5.  Anti-inflammatory drugs, prostaglandins and leucocyte migration.

Authors:  J R Walker; M J Smith; A W Ford-Hutchinson
Journal:  Agents Actions       Date:  1976-09

6.  Neutrophil preservation: the effect of short-term storage on in vivo kinetics.

Authors:  T H Price; D C Dale
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

7.  Arachidonic acid metabolism and the adhesion of human polymorphonuclear leukocytes to cultured vascular endothelial cells.

Authors:  M R Buchanan; M J Vazquez; M A Gimbrone
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

8.  Chemotactic response to some arachidonic acid lipoxygenase products in the rabbit eye.

Authors:  P Bhattacherjee; B Hammond; J A Salmon; R Stepney; K E Eakins
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

9.  Demonstration of inflammatory mediator-induced inflammation and endothelial cell damage in the anterior segment of the eye.

Authors:  F N Rowland; M J Donovan; M Lindsay; W I Weiss; J O'Rourke; D L Kreutzer
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

10.  Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.

Authors:  E A Ham; D D Soderman; M E Zanetti; H W Dougherty; E McCauley; F A Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

View more
  2 in total

1.  In vivo modulation of leukotaxis by non-steroidal anti-inflammatory drugs.

Authors:  T Shimanuki; R M Nakamura; G S diZerega
Journal:  Agents Actions       Date:  1985-10

2.  Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.

Authors:  Parth N Shah; Kimberly R Marshall-Batty; Justin A Smolen; Jasur A Tagaev; Qingquan Chen; Christopher A Rodesney; Henry H Le; Vernita D Gordon; David E Greenberg; Carolyn L Cannon
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.